Sluicebox Thursday, 06/11/20 12:39:53 PM Re: None Post # of 8038 Finally - money on the book to drive forward with CLR131, which looks very promising. Looking forward to update on two-cycle dosing cohort. Cheap and effective especially in the later lines where there are no alternatives for R/R MM R/R NHL having failed on tripple and quadruple combi and almost everything we can throw at these patients. Worth a listen https://viavid.webcasts.com/viewer/event.jsp?ei=1278219&tp_key=119af7bc64